Pathogenic variants in CDKN2A increase the risk for pancreatic cancer (~ 5% to 24% lifetime risk), and individuals with pathogenic variants in CDKN2A tend to have an earlier onset of cancer [65, 66]. The gene discussed is CDKN2A; the disease is familial pancreatic carcinoma.